Search results for: 'part cold consumer behavior saudi'

Wearable devices have often been dismissed by healthcare professionals as a consumer tool with 'fancy' features. With several consumer wearable devices now having regulatory clearances for detecting conditions like atrial fibrillation and other cardiac conditions, their role in the healthcare landscape is becoming prominent. COVID-19 induced lockdo...

The World Health Organization (WHO) made the following statement many years ago, “There is no health without mental health”. Today, as the COVID-19 pandemic ravages the world, another public health crisis is looming over our health systems—that of deteriorating mental health. Mass unemployment, salary reductions, depleting financial security nets, ...

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...

22 Jun 2020  |  North America  |  Technology Research

Analysing Sepsis Management Part I: Diagnosis

Recent Advances in Sepsis Diagnosis: PCR, Immunoassays, Sequencing and beyond

Infographics

×

Sepsis diagnosis The current research study discusses the understanding of sepsis, its epidemiology, sepsis diagnosis and unmet clinical need of rapid sepsis diagnosis, existing and developing diagnostic platforms for sepsis management including patents landscape, clinical studies, Regional analysis, companies and their sepsis diagnostic platforms...

The COVID-19 pandemic accelerated the shift toward greater adoption of decentralized healthcare, building trust by demonstrating the feasibility and ease of testing at home and in pharmacies with accurate results, including self-sampling options. Increasing technological advancements have created several opportunities for market expansion in direct...

Medicine production supply chains are currently operating under huge stress due to the war in Ukraine, COVID-19-related disruptions, logistics bottlenecks, and inflation. An energy-related shutdown of production would have a detrimental effect on the supply of critical medicines to patients in the EU and worldwide. The excessive amount of pressure ...

Frost & Sullivan has identified that the healthcare industry is witnessing massive disruption because of the digital revolution and competitive threats from new market entrants. COVID-19 exposed the strengths and weaknesses of healthcare organizations already striving to digitally transform their operations and create retail-like patient experi...

This research service analyzes the global market for wearable technologies in clinical and consumer health. It discusses in detail how industry convergence and technological innovations are transitioning wearables from simple consumer devices to actionable healthcare applications—specifically in managing targeted chronic diseases such as diabetes, ...

This research service presents an analysis of the cardiovascular drugs market in Saudi Arabia and the United Arab Emirates. It quantifies the market size and provides growth forecasts of the cardiovascular market from 2008 to 2017. This research service provides in-depth analysis of industry challenges, market drivers, and market restraints, and ho...